share_log

Eli Lilly Announced Topline Results From The SURMOUNT-5 Phase 3b Open-label Randomized Clinical Trial

Eli Lilly Announced Topline Results From The SURMOUNT-5 Phase 3b Open-label Randomized Clinical Trial

礼来公司宣布了SURMOUNt-5第30亿期开放标签随机临床试验的顶线结果
Benzinga ·  12/04 19:46

Eli Lilly Announced Topline Results From The SURMOUNT-5 Phase 3b Open-label Randomized Clinical Trial

Eli Lilly宣布从SURMOUNt-5第三十亿期开放式随机临床试验中获得了头号结果

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发